BSE filing, BSE: 543916. Summary written from the filing by ALFA Finder's alert engine.
Hemant Surgical Industries Ltd: key numbers
- Share price
- ₹573.60
- Market cap
- ₹747.9 Cr
- Revenue (annual)
- ₹231.8 Cr
- Net profit (annual)
- ₹18.19 Cr
- P/E (TTM)
- 41.1×Sector 52.8×
- Promoter holding
- 52.83%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hemant Surgical Industries Ltd
All →Hemant Surgical Industries Other Announcement
Hemant Surgical Industries Ltd filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd. conducted its 37th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements and ratified the Cost Auditor's remuneration.
Hemant Surgical Industries Other Announcement
The company informs the exchange that it has sent letters to shareholders with unregistered email addresses, providing a weblink for the AGM Notice and Integrated Annual Report.
Hemant Surgical Industries Annual Report
Hemant Surgical Industries Ltd has filed its Integrated Annual Report and Notice of the 37th Annual General Meeting for the financial year 2025-26.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd has scheduled its 37th Annual General Meeting for September 29, 2026, to be conducted through video conferencing.
Hemant Surgical Industries Board Meeting Outcome
Hemant Surgical Industries approved its Directors' Report and Management Discussion and Analysis for FY2026, and scheduled its 37th Annual General Meeting for September 29, 2026.
Other board meeting date announcements
All →Banas Finance Board Meeting Date
Banas Finance schedules a board meeting on 5 November 2026 to approve unaudited Q2 and half-year results. Trading window stays closed until 48 hours after results declaration.
Thirumalai Chemicals Board Meeting Date
Thirumalai Chemicals has informed the exchanges that its board will meet on November 5, 2026. The meeting will consider unaudited results for the quarter and half year ended September 30, 2026.
Super Spinning Mills Board Meeting Date
Super Spinning Mills schedules its board meeting for November 5, 2026 to consider unaudited quarterly results. Trading window stays closed until 48 hours after the meeting.
Lead Reclaim and Rubber Products Board Meeting Date
Lead Reclaim will meet on 05 November 2026 to consider half-yearly unaudited results for September 2026. Trading window remains closed until 07 November 2026.
Oval Projects Engineering Board Meeting Date
Oval Projects Engineering will hold a board meeting on November 4, 2026 to consider half-year results and a warrant issue. Agenda items are proposed; no amount stated.
Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.